- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-trimer
- Ligands
- 12 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 2 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN.2: 4 residues within 4Å:- Chain B: K.834, N.840, S.842, Q.843
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN.3: 9 residues within 4Å:- Chain B: K.1112, F.1114, V.1135, S.1136, N.1137, T.1139, H.1140, F.1142, Y.1149
1 PLIP interactions:1 interactions with chain B- Hydrophobic interactions: B:H.1140, B:F.1142
- Hydrogen bonds: B:T.1139, B:H.1140, B:H.1140, B:H.1140
- 8 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-covalent)
NAG-NAG.4: 4 residues within 4Å:- Chain A: N.319, E.320, N.321, T.323
No protein-ligand interaction detected (PLIP)NAG-NAG.6: 3 residues within 4Å:- Chain A: N.655, T.657, Q.683
No protein-ligand interaction detected (PLIP)NAG-NAG.8: 5 residues within 4Å:- Chain A: A.745, S.750, E.1111, K.1112, N.1113
No protein-ligand interaction detected (PLIP)NAG-NAG.12: 6 residues within 4Å:- Chain A: Y.746, S.747, N.748, N.749
- Chain B: I.833, D.835
No protein-ligand interaction detected (PLIP)NAG-NAG.14: 8 residues within 4Å:- Chain B: N.161, A.162, T.163, N.164, V.165, V.166, F.196, V.210
No protein-ligand interaction detected (PLIP)NAG-NAG.17: 5 residues within 4Å:- Chain B: A.745, S.750, N.1113, F.1114, T.1115
No protein-ligand interaction detected (PLIP)NAG-NAG.28: 3 residues within 4Å:- Chain A: I.833, D.835
- Chain C: N.748
No protein-ligand interaction detected (PLIP)NAG-NAG.29: 5 residues within 4Å:- Chain C: S.151, K.152, E.171, N.203, N.204
No protein-ligand interaction detected (PLIP)- 1 x NAG- NAG- BMA- FUC: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-3)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 2 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN.7: 8 residues within 4Å:- Chain A: N.756, F.757, T.758, L.961, N.964, Q.965, A.1109, Q.1110
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:L.961, A:Q.965
- Hydrogen bonds: A:Q.965
NAG-NAG-BMA-MAN.23: 9 residues within 4Å:- Chain C: T.755, N.756, F.757, T.758, N.958, L.961, Q.965, Q.1110, F.1148
No protein-ligand interaction detected (PLIP)- 1 x NAG- NAG- FUC: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 2 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 1 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-6)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 18 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.30: 7 residues within 4Å:- Chain A: N.161, A.162, T.163, N.164, V.166, K.168, V.210
Ligand excluded by PLIPNAG.31: 1 residues within 4Å:- Chain A: N.642
Ligand excluded by PLIPNAG.32: 4 residues within 4Å:- Chain A: E.693, H.694, V.695, N.696
Ligand excluded by PLIPNAG.33: 5 residues within 4Å:- Chain A: Y.67, T.68, N.69, F.98, N.100
Ligand excluded by PLIPNAG.34: 8 residues within 4Å:- Chain A: G.181, V.182, Y.183, N.188, S.190, W.191, M.192, S.194
Ligand excluded by PLIPNAG.35: 5 residues within 4Å:- Chain A: E.171, N.203, N.204, C.205
- Chain C: R.505
Ligand excluded by PLIPNAG.36: 3 residues within 4Å:- Chain B: Y.67, N.69, N.100
Ligand excluded by PLIPNAG.37: 7 residues within 4Å:- Chain B: F.368, P.369, N.370, I.371, T.372, Q.619, T.620
Ligand excluded by PLIPNAG.38: 2 residues within 4Å:- Chain B: N.642, T.643
Ligand excluded by PLIPNAG.39: 2 residues within 4Å:- Chain B: H.694, N.696
Ligand excluded by PLIPNAG.40: 5 residues within 4Å:- Chain B: G.378, F.381, N.382, L.407, F.413
Ligand excluded by PLIPNAG.41: 6 residues within 4Å:- Chain B: H.185, K.186, N.187, N.188, K.189, W.297
Ligand excluded by PLIPNAG.42: 6 residues within 4Å:- Chain A: R.396
- Chain B: Q.154, E.171, N.204, C.205, T.206
Ligand excluded by PLIPNAG.43: 3 residues within 4Å:- Chain C: F.98, S.99, N.100
Ligand excluded by PLIPNAG.44: 2 residues within 4Å:- Chain C: T.346, N.642
Ligand excluded by PLIPNAG.45: 2 residues within 4Å:- Chain C: H.694, N.696
Ligand excluded by PLIPNAG.46: 1 residues within 4Å:- Chain C: N.188
Ligand excluded by PLIPNAG.47: 5 residues within 4Å:- Chain C: T.147, T.148, T.153, N.273, T.275
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Singh, S. et al., Structure of SARS CoV-2 full-length spike protein with Lys1269Ala and His1271Ala substitutions in the coatomer binding motif, 2RBD-up conformation. To Be Published
- Release Date
- 2025-04-16
- Peptides
- Spike glycoprotein: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-trimer
- Ligands
- 12 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 2 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 8 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-covalent)
- 1 x NAG- NAG- BMA- FUC: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-3)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 2 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 1 x NAG- NAG- FUC: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 2 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 1 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-6)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 18 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Singh, S. et al., Structure of SARS CoV-2 full-length spike protein with Lys1269Ala and His1271Ala substitutions in the coatomer binding motif, 2RBD-up conformation. To Be Published
- Release Date
- 2025-04-16
- Peptides
- Spike glycoprotein: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C